AT256454T
Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose deivative
Abstract
The invention relates to a comprising graciousness of the friend and cleaning is a friend or a pharmaceutically-acceptable salt and crosslinking cellulose derivative oral and composition. The discovery of the composition which is, the crosslinking cellulose derivative capable of increasing the oral and composition graciousness of the friend or the cleaning for releasing rate of the friend. The crosslinking cellulose derivative's content of the composition is suitable at least is 6 weights %, a restraint 8% to 16 restraint weights %, specifically a restraint 10% to 14 restraint weights %.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
63 members in 40 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 15226398 | United States of America | A | |
| 9900740 | Finland | W |
Members63
| Document | Office | Kind | |
|---|---|---|---|
| CA2342634A1 | Canada | A1 | |
| WO0015196A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5748299A | Australia | A | |
| PE20001060A1 | Peru | A1 | |
| NO20011278D0 | Norway | D0 | |
| NO20011278L | Norway | L | |
| BR9913681A | Brazil | A | |
| EP1112065A1 | European Patent Office (EPO) | A1 | |
| ID29026A | Indonesia | A | |
| KR20010075084A | Republic of Korea | A | |
| CZ2001792A3 | Czechia | A3 | |
| EA200100354A1 | Eurasian Patent Organization (EAPO) | A1 | |
| TR200100752T2 | Türkiye | T2 | |
| CN1319005A | China | A | |
| BG105436A | Bulgaria | A | |
| HU0103454A2 | Hungary | A2 | |
| HUP0103454A2 | Hungary | A2 | |
| PL346618A1 | Poland | A1 | |
| CO5130008A1 | Colombia | A1 | |
| IL141681D0 | Israel | D0 | |
| AU746889B2 | Australia | B2 | |
| SK3072001A3 | Slovakia | A3 | |
| HK1039750A1 | Hong Kong, China | A1 | |
| ZA200102084B | South Africa | B | |
| EE200100147A | Estonia | A | |
| HRP20010277A2 | Croatia | A2 | |
| JP2002524493A | Japan | A | |
| AR021806A1 | Argentina | A1 | |
| US2002132009A1 | United States of America | A1 | |
| NZ510583A | New Zealand | A | |
| YU19301A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| EA003282B1 | Eurasian Patent Organization (EAPO) | B1 | |
| US6599530B2 | United States of America | B2 | |
| GEP20033062B | Georgia | B | |
| HU0103454A3 | Hungary | A3 | |
| HUP0103454A3 | Hungary | A3 | |
| EP1112065B1 | European Patent Office (EPO) | B1 | |
| AT256454TThis record | Austria | T | |
| ATE256454T1 | Austria | T1 | |
| DE69913714D1 | Germany | D1 | |
| DK1112065T3 | Denmark | T3 | |
| PT1112065E | Portugal | E | |
| SI1112065T1 | Slovenia | T1 | |
| CN1151778C | China | C | |
| SK284049B6 | Slovakia | B6 | |
| ES2213381T3 | Spain | T3 | |
| CZ293960B6 | Czechia | B6 | |
| DE69913714T2 | Germany | T2 | |
| TWI222367B | Taiwan Province of China | B | |
| HK1039750B | Hong Kong, China | B | |
| UA73925C2 | Ukraine | C2 | |
| MY124394A | Malaysia | A | |
| EE04657B1 | Estonia | B1 | |
| BG65041B1 | Bulgaria | B1 | |
| PL193454B1 | Poland | B1 | |
| KR100732187B1 | Republic of Korea | B1 | |
| ME00706B | Montenegro | B | |
| RS49723B | Serbia | B | |
| CA2342634C | Canada | C | |
| HRP20010277B1 | Croatia | B1 | |
| JP4619537B2 | Japan | B2 | |
| NO331641B1 | Norway | B1 | |
| HU228910B1 | Hungary | B1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Change in the person of patent ownerEEIH | EEIH | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 99944655
Titles2
- German
- PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND ENTACAPON ODER NITECAPON SOWIE EIN VERNETZTES CELLULOSEDERIVAT
- English
- PHARMACEUTICAL COMPOSITION CONTAINING ENTACAPONE OR NITECAPONE AND A NETWORKED CELLULOSE DERIVATIVE
Classification
- CPC, 5
- A61K9/2054
- A61K9/20
- A61P25/00
- A61P25/16
- A61P43/00
- IPC, 7
- A61K9 20
- A61K31 12
- A61K31 121
- A61K31 16
- A61K47 38
- A61P25 16
- A61P43 00